The global cell therapy human raw materials market size is expected to reach USD 22.39 Billion in 2034 from USD 4.83 Billion in 2025, growing at a CAGR of 18.58% during 2026-2034.The global cell therapy human raw materials market is witnessing strong growth driven by increasing research and commercialization of advanced cell-based therapies. Human-derived raw materials such as serum, growth factors, and cell culture media are essential in manufacturing cell therapies.
